From breast cancer to prostate cancer, the state of oncology care and how it will evolve.
What to expect for these high-dollar drugs.
The vaccines that could make a big impact on healthcare, from radical new flu vaccines to simplified meningococcal vaccine regimens.
The disease management and insurer initiatives changing the diabetes landscape.
The latest in RA therapies, and what you can expect from the pipeline.
Managed Healthcare Executive asked top experts their predictions for the top game-changing therapies. Here’s what they said.
The biggest drug categories and medications set for approval this year.
Major blockbuster drugs slated for launch in 2019 are expected to have a significant impact on treating certain cancers, diabetes, peanut allergies, and other conditions.
In the past week, the migraine prevention drug market has suddenly heated up, with 2 new approvals by FDA.
Vaccines are an important part of creating “herd immunity” to keep infectious diseases in check. Here are three vaccine developments that have far reaching implications for public health.